GH · Insider Trading
Guardant Health, Inc. Common Stock
Every open-market purchase and sale reported by GH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Chris Freeman | Chief Commercial Officer | MIXED | +4,273 | −$549.24K |
| 2026-10-02 | Terilyn J. Monroe | Chief People Officer | MIXED | +1,921 | −$366.63K |
| 2026-10-02 | Helmy Eltoukhy | Co-Chief Executive Officer | MIXED | +18,015 | −$3.24M |
| 2026-10-02 | Darya Chudova | Chief Technology Officer | MIXED | +3,713 | −$754.92K |
| 2026-10-02 | AmirAli Talasaz | Co-Chief Executive Officer | MIXED | +18,015 | −$3.24M |
| 2026-10-02 | Kumud Kalia | Chief Information Officer | MIXED | +2,979 | −$535.96K |
| 2026-10-02 | John G. Saia | Chief Legal Officer | MIXED | +3,357 | −$647.62K |
| 2026-10-02 | Michael Brian Bell | Chief Financial Officer | MIXED | +3,366 | −$683.97K |
| 2026-09-22 | Roberto Mignone | Director | M | +264 | — |
| 2026-09-21 | Medina Manuel Hidalgo | Director | M | +232 | — |
| 2026-09-17 | Darya Chudova | Chief Technology Officer | Sell | −7,738 | −$1.38M |
| 2026-09-17 | Alex M Azar II | Director | Sell | −826 | −$144.55K |
| 2026-09-17 | Musa Tariq | Director | MIXED | +133 | −$20.30K |
| 2026-09-17 | Steve E. Krognes | Director | Sell | −6,674 | −$1.17M |
| 2026-09-14 | Alex M Azar II | Director | M | +1,651 | — |
| 2026-09-14 | Kumud Kalia | Chief Information Officer | Sell | −4,000 | −$632.19K |
| 2026-08-27 | Helmy Eltoukhy | Co-Chief Executive Officer | MIXED | −30,000 | — |
| 2026-08-24 | Roberto Mignone | Director | M | +264 | — |
| 2026-08-24 | AmirAli Talasaz | Co-Chief Executive Officer | Sell | −37,500 | −$6.34M |
| 2026-08-18 | Musa Tariq | Director | MIXED | +134 | −$18.15K |
| 2026-08-18 | Medina Manuel Hidalgo | Director | M | +232 | — |
| 2026-08-13 | Terilyn J. Monroe | Chief People Officer | MIXED | — | −$6.59M |
| 2026-08-12 | Helmy Eltoukhy | Co-Chief Executive Officer | G | — | — |
| 2026-08-12 | John G. Saia | Chief Legal Officer | G | −800 | — |
| 2026-08-12 | AmirAli Talasaz | Co-Chief Executive Officer | G | — | — |
| 2026-08-11 | Chris Freeman | Chief Commercial Officer | MIXED | — | −$6.07M |
| 2026-08-06 | Medina Manuel Hidalgo | Director | MIXED | −750 | −$248.28K |
| 2026-08-06 | Medina Manuel Hidalgo | Director | MIXED | −750 | −$248.28K |
| 2026-08-05 | Ian T Clark | Director | MIXED | −5,092 | −$1.70M |
| 2026-07-22 | Roberto Mignone | Director | M | +264 | — |
| 2026-07-20 | Medina Manuel Hidalgo | Director | M | +232 | — |
| 2026-07-16 | Musa Tariq | Director | MIXED | +134 | −$18.94K |
| 2026-07-02 | Terilyn J. Monroe | Chief People Officer | MIXED | +1,921 | −$358.45K |
| 2026-07-02 | AmirAli Talasaz | Co-Chief Executive Officer | MIXED | +18,015 | −$3.13M |
| 2026-07-02 | Chris Freeman | Chief Commercial Officer | MIXED | +4,273 | −$536.39K |
| 2026-07-02 | Steve E. Krognes | Director | M | +155 | — |
| 2026-07-02 | Helmy Eltoukhy | Co-Chief Executive Officer | MIXED | +18,015 | −$3.13M |
| 2026-07-02 | John G. Saia | Chief Legal Officer | MIXED | +3,356 | −$633.04K |
| 2026-07-02 | Kumud Kalia | Chief Information Officer | MIXED | +2,980 | −$523.58K |
| 2026-07-02 | Michael Brian Bell | Chief Financial Officer | MIXED | +3,364 | −$668.39K |
| 2026-07-02 | Darya Chudova | Chief Technology Officer | MIXED | +3,712 | −$737.38K |
| 2026-06-23 | Musa Tariq | Director | Sell | −1,951 | −$255.89K |
| 2026-06-23 | Roberto Mignone | Director | M | +528 | — |
| 2026-06-23 | Myrtle S Potter | Director | Sell | −1,556 | −$204.08K |
| 2026-06-22 | Alex M Azar II | Director | A | +2,711 deriv. | — |
| 2026-06-22 | Musa Tariq | Director | M | +4,203 | — |
| 2026-06-22 | Vijaya Gadde | Director | M | +4,203 | — |
| 2026-06-22 | Ian T Clark | Director | M | +5,092 | — |
| 2026-06-22 | Meghan V. Joyce | Director | M | +4,203 | — |
| 2026-06-22 | Roberto Mignone | Director | M | +4,203 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Helmy Eltoukhy | Co-Chief Executive Officer | 1,966,320 | $349.61M |
| AmirAli Talasaz | Co-Chief Executive Officer | 1,827,168 | $324.87M |
| Darya Chudova | Chief Technology Officer | 146,812 | $26.10M |
| Craig Eagle | Chief Medical Officer | 77,780 | $13.83M |
| Chris Freeman | Chief Commercial Officer | 67,303 | $11.97M |
| Michael Brian Bell | Chief Financial Officer | 59,096 | $10.51M |
| John G. Saia | Chief Legal Officer | 46,054 | $8.19M |
| Kumud Kalia | Chief Information Officer | 45,840 | $8.15M |
| Vijaya Gadde | Director | 28,517 | $5.07M |
| Terilyn J. Monroe | Chief People Officer | 26,998 | $4.80M |
| Myrtle S Potter | Director | 20,971 | $3.73M |
| Meghan V. Joyce | Director | 15,386 | $2.74M |
| Musa Tariq | Director | 11,449 | $2.04M |
| Ian T Clark | Director | 10,322 | $1.84M |
| Roberto Mignone | Director | 10,274 | $1.83M |
| Steve E. Krognes | Director | 7,906 | $1.41M |
| Medina Manuel Hidalgo | Director | 5,020 | $892.56K |
| Alex M Azar II | Director | 825 | $146.69K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the GH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.